These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23252355)

  • 21. Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes.
    Hernandez P; Balter M; Bourbeau J; Hodder R
    Respir Med; 2009 Jul; 103(7):1004-12. PubMed ID: 19269150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs of COPD exacerbations in the emergency department and inpatient setting.
    Dalal AA; Shah M; D'Souza AO; Rane P
    Respir Med; 2011 Mar; 105(3):454-60. PubMed ID: 20869226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic obstructive pulmonary disease: diagnosis and management.
    Downs CA; Appel SJ
    J Am Acad Nurse Pract; 2007 Mar; 19(3):126-32. PubMed ID: 17341279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic obstructive pulmonary disease: the disease and its burden to society.
    Halpin DM; Miravitlles M
    Proc Am Thorac Soc; 2006 Sep; 3(7):619-23. PubMed ID: 16963544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Costs of chronic obstructive pulmonary disease treatment].
    Targowski T; Jahnz-Rózyk K
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():86-7. PubMed ID: 15524026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transition of patients with COPD across different care settings: challenges and opportunities for hospitalists.
    Chuang C
    Hosp Pract (1995); 2012 Feb; 40(1):176-85. PubMed ID: 22406893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Integrated care for patients with advanced chronic obstructive pulmonary disease].
    Jassem E; Górecka D; Krakowiak P; Kozielski J; Słomiński JM; Krajnik M; Fal AM
    Pneumonol Alergol Pol; 2010; 78(2):126-32. PubMed ID: 20306424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translating new understanding into better care for the patient with chronic obstructive pulmonary disease.
    Pierson DJ
    Respir Care; 2004 Jan; 49(1):99-109. PubMed ID: 14733626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and global impact of chronic obstructive pulmonary disease.
    Mannino DM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients.
    Christenhusz LC; Prenger R; Pieterse ME; Seydel ER; van der Palen J
    Nicotine Tob Res; 2012 Jun; 14(6):657-63. PubMed ID: 22180589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-management support and other alternatives to reduce the burden of asthma and chronic obstructive pulmonary disease.
    Reddel HK; Jenkins CR; Partridge MR
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1396-406. PubMed ID: 25517803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the management of chronic obstructive pulmonary disease.
    Miller RM; George D; Halbert RJ
    J Healthc Qual; 2005; 27(2):42-7. PubMed ID: 16190311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of illness and economic evaluation for COPD.
    Ramsey SD; Sullivan SD
    Eur Respir J Suppl; 2003 Jun; 41():29s-35s. PubMed ID: 12795329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the need for a clinical COPD care program in a managed care organization.
    Cannon HE
    J Manag Care Pharm; 2004 Jul; 10(4 Suppl):S17-21. PubMed ID: 15253683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the financial crisis on COPD burden: Greece as a case study.
    Kotsiou OS; Zouridis S; Kosmopoulos M; Gourgoulianis KI
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature.
    Anees Ur Rehman ; Ahmad Hassali MA; Muhammad SA; Shah S; Abbas S; Hyder Ali IAB; Salman A
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):661-672. PubMed ID: 31596632
    [No Abstract]   [Full Text] [Related]  

  • 37. COPD service delivery in the UK.
    Stockley RA
    Lancet Respir Med; 2016 Jun; 4(6):426-8. PubMed ID: 27185521
    [No Abstract]   [Full Text] [Related]  

  • 38. The cost of breathing: an economic analysis of the patient cost of home oxygen therapy.
    Reisfield GM; Wilson GR
    Am J Hosp Palliat Care; 2004; 21(5):348-52. PubMed ID: 15510571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for the management of chronic obstructive pulmonary disease.
    Buist AS
    Respir Med; 2002 Aug; 96 Suppl C():S11-6. PubMed ID: 12199486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health outcomes assessment and economic evaluation in COPD: challenges and opportunities.
    Sullivan SD; Buist AS; Weiss K
    Eur Respir J Suppl; 2003 Jun; 41():1s-3s. PubMed ID: 12795325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.